{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:05:37Z","timestamp":1790222737075,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.diabres.2015.10.007","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T23:10:15Z","timestamp":1445555415000},"page":"276-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status"],"prefix":"10.1016","volume":"110","author":[{"given":"Moran","family":"Lavie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dor","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphna","family":"Vilozni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinat","family":"Forschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifat","family":"Sarouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Kanety","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Hemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Efrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalit","family":"Modan-Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2015.10.007_bib0210","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic Fibrosis-Related Diabetes: current trends in prevalence, incidence and mortality","volume":"32","author":"Dunitz","year":"2009","journal-title":"Diabetes Care"},{"issue":"December (12)","key":"10.1016\/j.diabres.2015.10.007_bib0215","first-page":"2677","article-title":"CFRD Consensus Conference Committee; epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review","volume":"33","author":"Becker","year":"2010","journal-title":"Diabetes Care"},{"issue":"September (15 Suppl. 20)","key":"10.1016\/j.diabres.2015.10.007_bib0220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/pedi.12178","article-title":"Management of cystic fibrosis-related diabetes in children and adolescents","author":"Moran","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.diabres.2015.10.007_bib0225","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0046-8177(84)80191-4","article-title":"Endocrine pancreas in cystic fibrosis: an immunohistochemical study","volume":"15","author":"Mukai","year":"1984","journal-title":"Hum Pathol"},{"key":"10.1016\/j.diabres.2015.10.007_bib0230","first-page":"1267","article-title":"Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis","volume":"81","author":"O\u2019Brien","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2015.10.007_bib0235","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2337\/diabetes.48.5.1082","article-title":"Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis","volume":"48","author":"LeBlanc","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2015.10.007_bib0240","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1464-5491.2002.00666.x","article-title":"Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction","volume":"19","author":"Noormohamed","year":"2002","journal-title":"Diabetes Med"},{"key":"10.1016\/j.diabres.2015.10.007_bib0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0026-0495(94)90239-9","article-title":"Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis","volume":"43","author":"Nelson","year":"1994","journal-title":"Metabolism"},{"issue":"April (4)","key":"10.1016\/j.diabres.2015.10.007_bib0250","first-page":"540","article-title":"Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis","volume":"152","author":"Laborde","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.diabres.2015.10.007_bib0255","article-title":"The multifaceted and controversial immunometabolic actions of adiponectin","author":"Xu","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.diabres.2015.10.007_bib0260","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1210\/jc.2006-1683","article-title":"Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients","volume":"92","author":"Stein","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2015.10.007_bib0265","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1152\/japplphysiol.00781.2009","article-title":"Obesity and lung inflammation","volume":"108","author":"Mancuso","year":"2010","journal-title":"J Appl Physiol (1985)"},{"issue":"3","key":"10.1016\/j.diabres.2015.10.007_bib0270","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.diabet.2007.01.004","article-title":"Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis","volume":"33","year":"2007","journal-title":"Diabetes Metab"},{"issue":"4","key":"10.1016\/j.diabres.2015.10.007_bib0275","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jc.2005-2135","article-title":"Body composition and adiponectin serum concentrations in adult patients with cystic fibrosis","volume":"91","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2015.10.007_bib0280","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcf.2007.10.003","article-title":"Adiponectin and body composition in cystic fibrosis","volume":"7","author":"Fotoulaki","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"December (6)","key":"10.1016\/j.diabres.2015.10.007_bib0285","first-page":"483","article-title":"Normal total and high molecular weight adiponectin levels in adults with cystic fibrosis","volume":"10","author":"Elisha","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabres.2015.10.007_bib0290","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-3476(88)80315-9","article-title":"Diabetes mellitus associated with cystic fibrosis","volume":"112","author":"Wielinski","year":"1988","journal-title":"J Pediatr"},{"key":"10.1016\/j.diabres.2015.10.007_bib0295","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/BF01957574","article-title":"Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis","volume":"151","author":"Thorsteinsson","year":"1992","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.diabres.2015.10.007_bib0300","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1542\/peds.108.6.e108","article-title":"Comparison of body weight and height of Israeli schoolchildren with the tanner and centers for disease control and prevention growth charts","volume":"108","author":"Haelyon","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.diabres.2015.10.007_bib0305","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Viegi","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.diabres.2015.10.007_bib0310","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1056\/NEJM199310283291804","article-title":"Correlation between genotype and phenotype in patients with cystic fibrosis","volume":"329","author":"The Cystic Fibrosis Genotype-Phenotype Consortium","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2015.10.007_bib0315","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ppul.20286","article-title":"Diagnosis and treatment of intestinal malabsorption in cystic fibrosis","volume":"41","author":"Wolfe","year":"2006","journal-title":"Pediatr Pulmonol"},{"issue":"January (1)","key":"10.1016\/j.diabres.2015.10.007_bib0320","first-page":"E15","article-title":"Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage","volume":"294","author":"Lee","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.diabres.2015.10.007_bib0325","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diacare.24.3.539","article-title":"A model-based method for assessing insulin sensitivity from the oral glucose tolerance test","volume":"24","author":"Pacini","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2015.10.007_bib0330","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1464-5491.1994.tb00273.x","article-title":"Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and secretion","volume":"11","author":"Phillips","year":"1994","journal-title":"Diabetes Med"},{"issue":"January (Suppl. 1)","key":"10.1016\/j.diabres.2015.10.007_bib0335","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.2337\/dc15-S005","article-title":"Classification and diagnosis of diabetes","volume":"38","author":"Association","year":"2015","journal-title":"Diabetes Care"},{"issue":"January (1)","key":"10.1016\/j.diabres.2015.10.007_bib0340","first-page":"125","article-title":"ECFS Patient Registry Steering Group Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry","volume":"43","author":"Viviani","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.diabres.2015.10.007_bib0345","first-page":"860","article-title":"Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy","volume":"90","author":"Benali","year":"2001","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.diabres.2015.10.007_bib0350","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/dc09-1492","article-title":"Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain","volume":"33","author":"Morton","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2015.10.007_bib0355","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2007.03.006","article-title":"Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis","volume":"151","author":"Morgan","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.diabres.2015.10.007_bib0360","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/ajrccm.162.3.9904075","article-title":"Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline","volume":"162","author":"Warwick","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.diabres.2015.10.007_bib0365","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.diabet.2013.02.001","article-title":"Insulin and atherosclerosis: how are they related?","volume":"39","author":"Monnier L1","year":"2013","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2015.10.007_bib0370","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jcf.2008.01.004","article-title":"Oxidative stress and cystic fibrosis-related diabetes: a pilot study in children","volume":"7","author":"Ntimbane T1","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabres.2015.10.007_bib0375","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcf.2006.03.009","article-title":"Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis","volume":"6","author":"Brennan AL1","year":"2007","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabres.2015.10.007_bib0380","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ajcn.81.2.421","article-title":"Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis","volume":"81","author":"Chapman","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.diabres.2015.10.007_bib0385","first-page":"1170","article-title":"Early childhood risk factors for decreased FEV1 at age six to seven years in young children with cystic fibrosis","volume":"12","author":"Emerson","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.diabres.2015.10.007_bib0390","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/adc.87.5.430","article-title":"Clinical improvement in cystic fibrosis with early insulin treatment","volume":"87","author":"Hattersley","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.diabres.2015.10.007_bib0395","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1399-5448.2008.00451.x","article-title":"One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements","volume":"10","author":"Franzese","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.diabres.2015.10.007_bib0400","doi-asserted-by":"crossref","first-page":"RC1","DOI":"10.1007\/BF03345538","article-title":"Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance","volume":"29","author":"Lucidi","year":"2006","journal-title":"J Endocrinol Invest"},{"issue":"February (2)","key":"10.1016\/j.diabres.2015.10.007_bib0405","first-page":"292","article-title":"Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis","volume":"34","author":"Dougherty","year":"2011","journal-title":"Diabetes Care"},{"issue":"December (12)","key":"10.1016\/j.diabres.2015.10.007_bib0410","first-page":"2697","volume":"33","author":"Brunzell","year":"2010","journal-title":"Diabetes Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822715004076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822715004076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T20:30:20Z","timestamp":1567283420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822715004076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0168822715004076"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2015.10.007","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2015.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}